15,012 Shares in Itron, Inc. $ITRI Acquired by Expect Equity LLC

Expect Equity LLC bought a new position in shares of Itron, Inc. (NASDAQ:ITRI) during the 2nd quarter, HoldingsChannel.com reports. The fund bought 15,012 shares of the scientific and technical instruments company’s stock, valued at approximately $1,299,000.

A number of other hedge funds have also bought and sold shares of ITRI. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Itron by 343.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after buying an additional 268 shares during the period. M&T Bank Corp grew its holdings in shares of Itron by 10.0% during the second quarter. M&T Bank Corp now owns 2,141 shares of the scientific and technical instruments company’s stock valued at $282,000 after buying an additional 194 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Itron by 25.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after acquiring an additional 81 shares during the period. Jump Financial LLC purchased a new position in Itron in the 2nd quarter worth $1,609,000. Finally, Cerity Partners LLC raised its stake in Itron by 10.2% in the 2nd quarter. Cerity Partners LLC now owns 5,431 shares of the scientific and technical instruments company’s stock worth $715,000 after acquiring an additional 503 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Itron Stock Performance

ITRI opened at $98.73 on Wednesday. Itron, Inc. has a 1 year low of $77.77 and a 1 year high of $142.00. The company has a debt-to-equity ratio of 0.96, a current ratio of 2.75 and a quick ratio of 2.29. The stock has a market cap of $4.32 billion, a P/E ratio of 16.48, a P/E/G ratio of 1.18 and a beta of 1.30. The firm has a fifty day moving average price of $91.23 and a 200 day moving average price of $90.07.

Itron (NASDAQ:ITRI) last posted its quarterly earnings data on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.29 by $0.30. Itron had a net margin of 11.90% and a return on equity of 19.26%. The business had revenue of $562.90 million for the quarter, compared to the consensus estimate of $566.34 million. During the same period last year, the firm posted $1.62 earnings per share. The company’s revenue was down 7.2% compared to the same quarter last year. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. Equities research analysts anticipate that Itron, Inc. will post 6.41 earnings per share for the current year.

Itron News Roundup

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Wall Street remains broadly constructive on ITRI. Eight analysts rate the stock Buy, compared with four Holds and one Sell, with an average price target of $131.33—well above its recent trading level. Recent Buy ratings and target increases from Needham, Seaport Research Partners and Roth Capital reinforce the bullish outlook. Itron analyst ratings
• Positive Sentiment: Institutional ownership remains substantial at 96.19%. California State Teachers’ Retirement System sharply increased its position during the second quarter, while Norges Bank, Jupiter Topco, Soros Fund Management and Millennium Management also reported significant holdings or purchases. This institutional support may help underpin the stock. Itron institutional ownership
• Neutral Sentiment: Reported short interest was listed at zero shares, producing a zero-day short-interest ratio. Because the data also shows an invalid percentage change, it offers little useful information about current bearish positioning or potential short-covering demand.
• Negative Sentiment: Several Itron executives recently sold shares, including CFO Joan S. Hooper’s sale of 4,406 shares on August 20 and an additional 455 shares on August 24. Multiple senior vice presidents and the chief accounting officer also sold smaller amounts. The filings state that the transactions covered tax-withholding obligations from vested equity awards, and the executives retained sizable positions, making the signal less concerning than open-market selling—but the cluster of sales could still pressure investor sentiment. Itron SEC insider-sale filing
• Negative Sentiment: The latest quarterly results showed strong EPS of $1.59 versus the $1.29 consensus estimate, but revenue declined 7.2% year over year to $562.9 million and fell slightly short of estimates. That softer revenue trend remains a fundamental risk despite the company’s maintained 2026 earnings guidance.

Analysts Set New Price Targets

ITRI has been the subject of a number of research reports. Zacks Research raised Itron from a “strong sell” rating to a “hold” rating in a research report on Wednesday, July 29th. TD Cowen cut their price objective on Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Needham & Company LLC lifted their target price on Itron from $116.00 to $128.00 and gave the stock a “buy” rating in a report on Wednesday, July 29th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Itron in a report on Wednesday, August 5th. Finally, Roth Capital reiterated a “buy” rating and issued a $136.00 target price on shares of Itron in a research report on Wednesday, April 29th. Eight analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $131.33.

Insider Activity

In related news, SVP John F. Marcolini sold 331 shares of the company’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $98.79, for a total transaction of $32,699.49. Following the completion of the sale, the senior vice president owned 12,683 shares of the company’s stock, valued at approximately $1,252,953.57. This represents a 2.54% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Donald L. Reeves III sold 329 shares of the stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $98.79, for a total transaction of $32,501.91. Following the completion of the sale, the senior vice president owned 27,945 shares of the company’s stock, valued at approximately $2,760,686.55. The trade was a 1.16% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 7,410 shares of company stock worth $731,178 over the last three months. Insiders own 1.77% of the company’s stock.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.